|
94
|
295
|
5deyA |
Crystal structure of pak1 in complex with an inhibitor compound g-5555 |
|
97
|
293
|
5dfpA |
Crystal structure of pak1 in complex with an inhibitor compound frax1036 |
|
107
|
389
|
5cyzA |
Structure of s. cerevisiae hrr25:mam1 complex, form 1 |
|
84
|
297
|
5di1A |
Map4k4 in complex with an inhibitor |
|
2
|
16
|
5de2C |
Structural mechanism of nek7 activation by nek9-induced dimerisation |
|
100
|
295
|
5dewA |
Crystal structure of pak1 in complex with an inhibitor compound 5 |
|
81
|
298
|
5d9kA |
Rsk2 n-terminal kinase in complex with bi-d1870 |
|
97
|
332
|
4yomB |
Structure of sad kinase |
|
102
|
297
|
4yo6A |
Irak4-inhibitor co-structure |
|
101
|
328
|
5cquA |
Monoclinic complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
73
|
318
|
4z8lA |
Crystal structure of dcaf1/siv-mnd vpx/mnd samhd1 ntd ternary complex |
|
113
|
328
|
5cx9A |
Crystal structure of ck2alpha with (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoate bound |
|
100
|
335
|
4ynzA |
Structure of the n-terminal domain of sad |
|
112
|
327
|
5cu6A |
Crystal structure of ck2alpha |
|
78
|
273
|
5csxA |
Crystal structure of b-raf in complex with bi 882370 |
|
112
|
327
|
5cu4A |
Crystal structure of ck2alpha with compound 10 bound |
|
78
|
273
|
5ct7A |
Braf in complex with raf265 |
|
107
|
331
|
5cqwA |
Tetragonal complex structure of protein kinase ck2 catalytic subunit with a benzotriazole-based inhibitor generated by click-chemistry |
|
82
|
318
|
5ajaA |
Crystal structure of mandrill samhd1 (amino acid residues 1-114) bound to vpx isolated from mandrill and human dcaf1 (amino acid residues 1058-1396) |
|
80
|
282
|
4yffA |
Tnni3k complexed with inhibitor 2 |
|
92
|
294
|
4ypdA |
Crystal structure of dapk1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine |
|
116
|
325
|
5cu3A |
Crystal structure of ck2alpha with compound 10 bound |
|
1
|
36
|
5csjC |
S100b-rsk1 crystal structure b |
|
84
|
274
|
4yznA |
Humanized roco4 bound to compound 19 |
|
75
|
273
|
5cswA |
B-raf in complex with dabrafenib |
|
84
|
296
|
4zp5A |
Map4k4 in complex with inhibitor |
|
118
|
400
|
4yveA |
Rock 1 bound to methoxyphenyl thiazole inhibitor |
|
113
|
326
|
5cvgA |
Crystal structure of ck2alpha with a novel closed conformation of the ad loop |
|
111
|
327
|
5cvfA |
Crystal structure of ck2alpha with compound 5 bound |
|
110
|
324
|
5cshA |
Crystal structure of ck2alpha with compound 4 bound |
|
113
|
328
|
5cu2A |
Crystal structure of ck2alpha with 2-hydroxy-5-methylbenzoic acid and (methyl 4-((3-(3-chloro-4-(phenyl)benzylamino)propyl)amino)-4-oxobutanoat bound |
|
112
|
327
|
5cs6A |
Crystal structure of ck2alpha with compound 3 bound |
|
80
|
289
|
5ajqA |
Human lok (stk10) in complex with bosutinib |
|
107
|
402
|
4yzdA |
Crystal structure of human phosphorylated ire1alpha in complex with adp-mg |
|
101
|
358
|
5airA |
Structural analysis of mouse gsk3beta fused with lrp6 peptide. |
|
78
|
286
|
4yfiA |
Tnni3k complexed with inhibitor 1 |
|
112
|
327
|
5cvhA |
Crystal structure of ck2alpha |
|
23
|
118
|
4yomA |
Structure of sad kinase |
|
111
|
326
|
5ct0A |
Crystal structure of ck2alpha with 3-(3-chloro-4-(phenyl)benzylamino)propan-1-ol bound |
|
110
|
327
|
5csvA |
Crystal structure of ck2alpha with compound 6 bound |
|
2
|
19
|
5csnC |
S100b-rsk1 crystal structure c |
|
77
|
271
|
4yhtA |
Braf complexed with an inhibitor |
|
84
|
297
|
5cwzA |
Crystal structure of the kinase domain of human traf2 and nck-interacting protein kinase |
|
60
|
276
|
4yzmA |
Humanized roco4 bound to lrrk2-in1 |
|
111
|
324
|
5ctpA |
Crystal structure of ck2alpha with n-(3-(3-chloro-4-(phenyl)benzylamino)propyl)acetamide bound |
|
105
|
402
|
4yzcA |
Crystal structure of pire1alpha in complex with staurosporine |
|
269
|
949
|
4xx5A |
Structure of pi3k gamma in complex with an inhibitor |
|
102
|
403
|
4yz9A |
Crystal structure of human phosphorylated ire1alpha in complex with a type iii kinase inhibitor (gsk2850163a) |
|
278
|
943
|
4wwpA |
Crystal structure of human pi3k-gamma in complex with pyridinylquinoline inhibitor n-{(1s)-1-[8-chloro-2-(2-methylpyridin-3-yl)quinolin-3-yl]ethyl}-9h-purin-6-amine |
|
78
|
277
|
5ci7A |
Structure of ulk1 bound to a selective inhibitor |